PMC:7293470 / 2460-2604 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T84","span":{"begin":6,"end":15},"obj":"CL:0000097"},{"id":"T85","span":{"begin":52,"end":74},"obj":"CHEBI:35472;CHEBI:35472"},{"id":"T86","span":{"begin":106,"end":117},"obj":"CHEBI:26995;CHEBI:26995"},{"id":"T96679","span":{"begin":6,"end":15},"obj":"CL:0000097"},{"id":"T70624","span":{"begin":52,"end":74},"obj":"CHEBI:35472;CHEBI:35472"},{"id":"T40591","span":{"begin":106,"end":117},"obj":"CHEBI:26995;CHEBI:26995"}],"text":", and mast cell secretion-blocking effects. A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leu"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T31","span":{"begin":6,"end":15},"obj":"Body_part"},{"id":"T32","span":{"begin":11,"end":15},"obj":"Body_part"}],"attributes":[{"id":"A31","pred":"fma_id","subj":"T31","obj":"http://purl.org/sig/ont/fma/fma66784"},{"id":"A32","pred":"fma_id","subj":"T32","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":", and mast cell secretion-blocking effects. A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leu"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T47","span":{"begin":11,"end":15},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T48","span":{"begin":44,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":", and mast cell secretion-blocking effects. A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leu"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T36","span":{"begin":52,"end":74},"obj":"Chemical"},{"id":"T37","span":{"begin":70,"end":74},"obj":"Chemical"},{"id":"T38","span":{"begin":87,"end":97},"obj":"Chemical"},{"id":"T39","span":{"begin":106,"end":117},"obj":"Chemical"},{"id":"T40","span":{"begin":131,"end":140},"obj":"Chemical"}],"attributes":[{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_35472"},{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_26995"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_23511"},{"id":"A41","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_32460"}],"text":", and mast cell secretion-blocking effects. A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leu"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T10","span":{"begin":16,"end":25},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":", and mast cell secretion-blocking effects. A third anti-inflammatory drug combined an antagonist for the thromboxane receptor and cysteinyl-leu"}